Reference health

Use of Proceeds in Private Equity-Backed Initial Public Offerings *

https://doi.org/10.2139/ssrn.4747463
CiteStamped reference-health badge
55/55 checkable references clean · checked 2026-08-27

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

10 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 55 checked references that resolve
resolves10.1111/j.1540-6261.2011.01699.x
Why Don't U.S. Issuers Demand European Fees for IPOs?
resolves10.1093/rfs/hhs117
Corporate Governance and Value Creation: Evidence from Private Equity
resolves10.1093/rof/rfq031
Structure and Determinants of Financial Covenants in Leveraged Buyouts
resolves10.2307/1879431
The Market for "Lemons": Quality Uncertainty and the Market Mechanism
resolves10.1016/j.qref.2016.09.001
Intended use of proceeds and post-IPO performance
resolves10.1016/j.jcorpfin.2008.12.003
Intended use of proceeds and the long-run performance of seasoned equity issuers
resolves10.1016/0304-405X(86)90055-3
Investment banking, reputation, and the underpricing of initial public offerings
resolves10.1093/rfs/hhy078
Private Equity and Financial Fragility during the Crisis
resolves10.1016/0304-405X(86)90057-7
Capital raising, underwriting and the certification hypothesis
resolves10.1111/j.1540-6261.2006.00840.x
Initial Public Offerings: An Analysis of Theory and Practice
resolves10.1016/j.intfin.2018.12.002
Are venture capital and buyout backed IPOs any different?
resolves10.1177/1536867X0300300305
Multivariate Probit Regression using Simulated Maximum Likelihood
resolves10.1111/j.1540-6261.1990.tb02426.x
Initial Public Offerings and Underwriter Reputation
resolves10.1016/j.jfineco.2010.03.003
Going public to acquire? The acquisition motive in IPOs
resolves10.1093/rfs/12.2.249
A Theory of the Going-Public Decision
resolves10.1111/j.1540-6261.1994.tb04420.x
Investment Bank Reputation, Information Production, and Financial Intermediation
resolves10.1111/0022-1082.00242
The Seven Percent Solution
resolves10.1017/S0022109019000486
Media Coverage and IPO Pricing around the World
resolves10.1093/rfs/hhr141
Pay for Performance from Future Fund Flows: The Case of Private Equity
resolves10.1016/j.jfineco.2013.11.007
The evolution of capital structure and operating performance after leveraged buyouts: Evidence from U.S. corporate tax returns
resolves10.1016/j.jcorpfin.2011.11.003
Leverage and pricing of debt in LBOs
resolves10.1111/j.1475-679x.2004.00161.x
Do Insiders Manipulate Earnings When They Sell Their Shares in an Initial Public Offering?
resolves10.1007/978-3-030-38738-9_37-2
Buyout Financing
resolves10.1016/j.jfineco.2010.02.001
The role of private equity group reputation in LBO financing
resolves10.1016/j.jcorpfin.2020.101696
Private equity exits after IPOs
resolves10.1016/j.najef.2018.08.022
Are venture capitalist-backed IPOs more innovative? Evidence from an emerging market
resolves10.1016/j.jfineco.2016.06.003
What do private equity firms say they do?
resolves10.1111/j.1468-5957.2006.00610.x
Explaining the Short‐ and Long‐Term IPO Anomalies in the US by R&D
resolves10.1093/pan/mpr025
Entropy Balancing for Causal Effects: A Multivariate Reweighting Method to Produce Balanced Samples in Observational Studies
resolves10.1016/j.jcorpfin.2017.04.006
Inorganic growth strategies and the evolution of the private equity business model
resolves10.1016/j.jcorpfin.2022.102285
Pricing and value creation in private equity-backed buy-and-build strategies
resolves10.1016/j.jcorpfin.2019.03.001
The determinants of IPO withdrawal – Evidence from Europe
resolves10.1017/S0022109000004026
Initial Public Offerings in Hot and Cold Markets
resolves10.1111/1468-0262.00442
Efficient Estimation of Average Treatment Effects Using the Estimated Propensity Score
resolves10.1093/rcfs/cfab015
Private Equity and the Resolution of Financial Distress
resolves10.1093/rfs/hhr024
The Private Equity Advantage: Leveraged Buyout Firms and Relationship Banking
resolves10.1111/jofi.12703
Quid Pro Quo? What Factors Influence IPO Allocations to Investors?
resolves10.1257/jep.23.1.121
Leveraged Buyouts and Private Equity
resolves10.1016/j.jempfin.2004.10.003
The implications of IPO underpricing for the firm and insiders: Tests of asymmetric information theories
resolves10.1016/j.jcorpfin.2016.07.010
Warrants in underwritten IPOs: The Alternative Investment Market (AIM) experience
resolves10.1016/j.jfineco.2006.09.010
Motivations for public equity offers: An international perspective☆
resolves10.1111/j.1475-6803.1996.tb00584.x
THE COSTS OF RAISING CAPITAL
resolves10.1111/j.1475-679X.2007.00229.x
Disclosure of Intended Use of Proceeds and Underpricing in Initial Public Offerings
resolves10.1016/0304-405X(94)90035-3
Venture capitalists and the decision to go public
resolves10.1111/j.1755-053X.2010.01141.x
The Performance of Private Equity‐Backed IPOs
resolves10.1086/503644
Hot Markets, Investor Sentiment, and IPO Pricing*
resolves10.1111/1911-3846.12982
The impact of news media coverage on voluntary disclosure
resolves10.1111/j.1540-6261.1991.tb03770.x
Venture Capitalist Certification in Initial Public Offerings
resolves10.1016/j.jcorpfin.2016.10.005
Are private equity backed initial public offerings any different? Timing, information asymmetry and post-IPO survival
resolves10.1111/eufm.12049
Ranking Underwriters of European IPOs
resolves10.1016/j.jfineco.2007.11.008
Venture capital reputation and investment performance☆
resolves10.1111/0022-1082.25448
Why Do Companies Go Public? An Empirical Analysis
resolves10.1016/0304-405X(86)90054-1
Why new issues are underpriced
resolves10.1016/j.jcorpfin.2008.04.001
Seasoned equity offerings: What firms say, do, and how the market reacts
resolves10.1016/j.iref.2020.04.006
Patent growth and the long-run performance of VC-backed IPOs
The 10 references without a DOI — listed, not checked
no DOI — not checkedref7
no DOI — not checkedThe performance of reverse leveraged buyouts
no DOI — not checkedPrivate-Equity Firms Make an IPO Push
no DOI — not checkedref29
no DOI — not checkedref31
no DOI — not checkedref32
no DOI — not checkedFare Thee Well?
no DOI — not checkedref39
no DOI — not checkedref62
no DOI — not checkedref65
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-08-27 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.2139/ssrn.4747463"><img src="https://citestamp.com/citestamped/10.2139/ssrn.4747463/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.2139/ssrn.4747463/badge.svg)](https://citestamp.com/citestamped/10.2139/ssrn.4747463)